7929

    532321

    ZYDUSLIFE

    img img img img
    No Data Available

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    ZYDUS LIFESCIENCES LTD Share Price Today

    ZYDUS LIFESCIENCES LTD is currently trading at ₹1111.8, down by ₹2.0 from the previous close. The stock touched an intraday high of ₹1119.60 and a low of ₹1099.00 during the latest trading session. Over the past one year, ZYDUS LIFESCIENCES LTD has delivered a return of 14.15%, while the stock has gained 0.85% in the last one month.

    ZYDUS LIFESCIENCES LTD performance

    Today’s low Today’s high
    ₹ 1099.00 ₹ 1119.60
    ₹ 1108.70
    52 week low 52 week high
    ₹ 835.50 ₹ 1181.50
    ₹ 1108.70
    Open Price ₹ 1109.00
    Prev. Close ₹ 1113.80
    Volume (Shares) 837032.00
    Total traded value ₹ 9280.17
    Upper Circuit ₹ 1224.00
    Lower Circuit ₹ 1001.60
    info

    Investment Returns

    Over 1 Month 0.85% Over 3 Months 19.54% Over 6 Months 24.10% Over 1 Year 14.15%
    demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

    ZYDUS LIFESCIENCES LTD fundamentals


    • Market cap (Cr) 1,10,593.20
    • P/E Ratio (TTM) 31.07
    • Beta 0.74
    • Book Value / share 237.30
    • Return on equity 15.87%
    • EPS (TTM) 37.00
    • Dividend yield 0.09%
    • Net profit/quarter (Cr) 1,722.00
    info icon alternate text
    • Market cap (Cr) 1,10,613.20
    • P/E Ratio (TTM) 31.07
    • Beta 0.62
    • Book Value / share 237.30
    • Return on equity 15.87%
    • EPS (TTM) 37.00
    • Dividend yield 0.09%
    • Net profit/quarter (Cr) 1,722.00
    info icon alternate text

    ZYDUS LIFESCIENCES LTD Financials

    • Key Results
    • Key Ratios
    • Balance sheet
    • Cash Flow
    • Competition
    Open financial information
    Revenue
    Net income
    Particulars MAR 2026 (Values in Cr)
    Revenue 3564.60
    Operating Expense 2018.20
    Net Profit 1722.00
    Net Profit Margin (%) 48.30
    Earnings Per Share (EPS) 17.11
    EBITDA 2377.40
    Effective Tax Rate (%) 18.42
    Particulars DEC 2025 (Values in Cr)
    Revenue 2207.20
    Operating Expense 2344.90
    Net Profit 296.50
    Net Profit Margin (%) 13.43
    Earnings Per Share (EPS) 2.95
    EBITDA 612.70
    Effective Tax Rate (%) 15.86
    Particulars SEP 2025 (Values in Cr)
    Revenue 2808.80
    Operating Expense 1969.10
    Net Profit 1156.60
    Net Profit Margin (%) 41.17
    Earnings Per Share (EPS) 11.49
    EBITDA 1693.39
    Effective Tax Rate (%) 19.88
    Particulars JUN 2025 (Values in Cr)
    Revenue 2495.80
    Operating Expense 2270.50
    Net Profit 384.70
    Net Profit Margin (%) 15.41
    Earnings Per Share (EPS) 3.82
    EBITDA 742.50
    Effective Tax Rate (%) 18.99
    Particulars MAR 2025 (Values in Cr)
    Revenue 5633.50
    Operating Expense 2330.30
    Net Profit 2813.70
    Net Profit Margin (%) 49.94
    Earnings Per Share (EPS) 27.96
    EBITDA 3958.10
    Effective Tax Rate (%) 23.43
    Particulars MAR 2026 (Values in Cr)
    Revenue 11076.40
    Operating Expense 8602.70
    Net Profit 3559.80
    Net Profit Margin (%) 32.13
    Earnings Per Share (EPS) 35.38
    EBITDA 5425.99
    Effective Tax Rate (%) 18.76
    Particulars MAR 2025 (Values in Cr)
    Revenue 14590.10
    Operating Expense 8367.80
    Net Profit 5774.90
    Net Profit Margin (%) 39.58
    Earnings Per Share (EPS) 57.39
    EBITDA 8432.50
    Effective Tax Rate (%) 22.42
    Particulars MAR 2024 (Values in Cr)
    Revenue 10317.60
    Operating Expense 7655.09
    Net Profit 3441.50
    Net Profit Margin (%) 33.35
    Earnings Per Share (EPS) 34.01
    EBITDA 5134.90
    Effective Tax Rate (%) 18.82
    Particulars MAR 2023 (Values in Cr)
    Revenue 8421.20
    Operating Expense 7044.00
    Net Profit 1529.20
    Net Profit Margin (%) 18.15
    Earnings Per Share (EPS) 15.06
    EBITDA 2799.00
    Effective Tax Rate (%) 24.75
    Particulars MAR 2022 (Values in Cr)
    Revenue 7590.00
    Operating Expense 6532.40
    Net Profit 857.90
    Net Profit Margin (%) 11.30
    Earnings Per Share (EPS) 8.38
    EBITDA 1777.50
    Effective Tax Rate (%) 26.29
    Particulars MAR 2026 (Values in Cr)
    Book Value / Share 269.50
    ROE % 19.69
    ROCE % 20.30
    Total Debt to Total Equity 0.31
    EBITDA Margin 16.55
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 238.10
    ROE % 21.08
    ROCE % 24.56
    Total Debt to Total Equity 0.09
    EBITDA Margin 15.73
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 197.11
    ROE % 20.64
    ROCE % 23.94
    Total Debt to Total Equity 0.05
    EBITDA Margin 29.04
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 173.08
    ROE % 14.05
    ROCE % 16.25
    Total Debt to Total Equity 0.16
    EBITDA Margin 23.35
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 166.01
    ROE % 29.67
    ROCE % 14.44
    Total Debt to Total Equity 0.29
    EBITDA Margin 23.37
    Particulars MAR 2026 (Values in Cr)
    Book Value / Share 235.31
    ROE % 15.87
    ROCE % 15.90
    Total Debt to Total Equity 0.35
    EBITDA Margin 47.24
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 210.64
    ROE % 31.29
    ROCE % 30.47
    Total Debt to Total Equity 0.39
    EBITDA Margin 55.78
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 156.23
    ROE % 23.45
    ROCE % 22.73
    Total Debt to Total Equity 0.37
    EBITDA Margin 47.46
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 134.78
    ROE % 11.38
    ROCE % 13.31
    Total Debt to Total Equity 0.28
    EBITDA Margin 32.06
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 129.30
    ROE % 8.43
    ROCE % 9.84
    Total Debt to Total Equity 0.25
    EBITDA Margin 26.31
    Particulars MAR 2026 (Values in Cr)
    Cash & Short Term Investments 1416.60
    Total Assets 52406.60
    Total Liabilities 52406.60
    Total Equity 29582.20
    Share Outstanding 100
    Price to Book Ratio 3.70
    Return on Assets (%) 9.61
    Return on Capital (%) 12.19
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 2956.80
    Total Assets 37201.70
    Total Liabilities 37201.70
    Total Equity 26358.40
    Share Outstanding 100
    Price to Book Ratio 4.20
    Return on Assets (%) 12.16
    Return on Capital (%) 15.33
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 1105.10
    Total Assets 29280.80
    Total Liabilities 29280.80
    Total Equity 22101.60
    Share Outstanding 100
    Price to Book Ratio 6.43
    Return on Assets (%) 13.18
    Return on Capital (%) 16.88
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 573.10
    Total Assets 25756.40
    Total Liabilities 25756.40
    Total Equity 19688.30
    Share Outstanding 101
    Price to Book Ratio 3.65
    Return on Assets (%) 7.61
    Return on Capital (%) 9.4
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 1106.90
    Total Assets 27795.40
    Total Liabilities 27795.40
    Total Equity 19053.80
    Share Outstanding 102
    Price to Book Ratio 2.70
    Return on Assets (%) 16.14
    Return on Capital (%) 19.3
    Particulars MAR 2026 (Values in Cr)
    Cash & Short Term Investments 734.20
    Total Assets 33879.60
    Total Liabilities 33879.60
    Total Equity 23671.70
    Share Outstanding 100
    Price to Book Ratio 3.70
    Return on Assets (%) 10.50
    Return on Capital (%) 11.45
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 144.10
    Total Assets 32316.90
    Total Liabilities 32316.90
    Total Equity 21190.10
    Share Outstanding 100
    Price to Book Ratio 4.20
    Return on Assets (%) 17.86
    Return on Capital (%) 19.56
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 414.40
    Total Assets 24084.80
    Total Liabilities 24084.80
    Total Equity 15716.50
    Share Outstanding 100
    Price to Book Ratio 6.43
    Return on Assets (%) 14.28
    Return on Capital (%) 15.72
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 248.10
    Total Assets 20563.60
    Total Liabilities 20563.60
    Total Equity 13639.40
    Share Outstanding 101
    Price to Book Ratio 3.65
    Return on Assets (%) 7.43
    Return on Capital (%) 8.28
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 302.60
    Total Assets 17740.00
    Total Liabilities 17740.00
    Total Equity 13240.50
    Share Outstanding 102
    Price to Book Ratio 2.70
    Return on Assets (%) 4.83
    Return on Capital (%) 5.39
    Particulars MAR 2026 (Values in Cr)
    Net Income 6621.10
    Cash from Operations 3707.60
    Cash from Investing -8296.10
    Cash from Financing 5806.90
    Net change in Cash -372.60
    Free Cash Flow 6379.10
    Particulars MAR 2025 (Values in Cr)
    Net Income 6026.70
    Cash from Operations 8583.00
    Cash from Investing -8357.80
    Cash from Financing 1995.30
    Net change in Cash 418.60
    Free Cash Flow 10276.70
    Particulars MAR 2024 (Values in Cr)
    Net Income 4838.10
    Cash from Operations 4513.70
    Cash from Investing -1475.20
    Cash from Financing -1810.40
    Net change in Cash -57.70
    Free Cash Flow 5420.30
    Particulars MAR 2023 (Values in Cr)
    Net Income 2582.70
    Cash from Operations 3280.80
    Cash from Investing 1171.20
    Cash from Financing -4400.40
    Net change in Cash -540.40
    Free Cash Flow 4311.70
    Particulars MAR 2022 (Values in Cr)
    Net Income 5232.30
    Cash from Operations 2778.70
    Cash from Investing 1154.40
    Cash from Financing -868.30
    Net change in Cash 2390.20
    Free Cash Flow 3981.29
    Particulars MAR 2026 (Values in Cr)
    Net Income 4381.90
    Cash from Operations 3280.20
    Cash from Investing 569.60
    Cash from Financing -2579.90
    Net change in Cash 224.00
    Free Cash Flow 4179.20
    Particulars MAR 2025 (Values in Cr)
    Net Income 7444.70
    Cash from Operations 4462.10
    Cash from Investing -4503.60
    Cash from Financing 1384.50
    Net change in Cash -5.10
    Free Cash Flow 5367.00
    Particulars MAR 2024 (Values in Cr)
    Net Income 4239.80
    Cash from Operations 2898.00
    Cash from Investing -1831.80
    Cash from Financing -300.80
    Net change in Cash -132.30
    Free Cash Flow 3483.40
    Particulars MAR 2023 (Values in Cr)
    Net Income 2032.20
    Cash from Operations 1471.40
    Cash from Investing -1959.30
    Cash from Financing 827.00
    Net change in Cash -54.10
    Free Cash Flow 2221.50
    Particulars MAR 2022 (Values in Cr)
    Net Income 1163.90
    Cash from Operations 1580.70
    Cash from Investing 768.20
    Cash from Financing -1709.80
    Net change in Cash 369.10
    Free Cash Flow 2122.50
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENTERPRISES L 32.45 13.46 1.57 248.68 23.12 38.85
    BLISS GVS PHARMA LTD 463.55 37.26 4.12 4916.24 118.35 552.90
    CIPLA LTD. 1410.90 31.85 3.31 113978.90 1165.55 1672.20
    FERMENTA BIOTECH LTD. 432.60 20.23 3.13 1273.18 256.40 480.00
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENTERPRISES L 32.45 22.69 4.18 248.68 23.12 38.85
    AMRUTANJAN HEALTH CARE LTD. 510.50 22.88 3.98 1475.89 490.00 789.95
    ASTRAZENECA PHARMA IND LT 8000.10 104.55 22.91 20000.25 7630.00 9850.00
    BLISS GVS PHARMA LTD 463.55 50.11 4.25 4916.24 118.35 552.90

    ZYDUS LIFESCIENCES LTD shareholding pattern

    Holding
    6.82%
    75.01%
    6.88%
    11.27%
    Name Shares Category
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)

    News

    Left Arrow
    Right Arrow

    ZYDUS LIFESCIENCES LTD Technicals Summary

    • EMA & SMA
    • Resistance and Support
    • Delivery and Volume
    • Beta
    • Price Change Analysis
    1108.70 -0.45 redarrow
    red-green-graph indicator
    10 Bearish
    6 Bullish
    • 5 Days 1123.60
    • 26 Days 1120.70
    • 10 Days 1130.50
    • 50 Days 1088.00
    • 12 Days 1131.00
    • 100 Days 1037.00
    • 20 Days 1127.00
    • 200 Days 999.80
    1116.43 PIVOT
    First Support 1103.87 First Resistance 1126.37 Second Support 1093.93 Second Resistance 1138.93 Third Support 1081.37 Third Resistance 1148.87
    RSI 46.17 ADX 38.02 MACD 10.33 Williams % R -88.24 Commodity Channel Index (CCI) -112.91
    Date 2026-07-24 Week 547250.00 Same Day 447545.00 Month 705937.00
    1 Year 0.75 3 Year 0.70
    Over 1 Month
    0.85% down
    Over 1 Year
    14.15% down
    Over 3 Months
    19.54% down
    Over 3 Years
    21.78% down
    Over 6 Months
    24.10% down
    Over 5 Years
    12.85% down

    ZYDUS LIFESCIENCES LTD Corporate Actions

    Dividend date Dividend amount Dividend type Record date Instrument type
    24 Jul 2026 1.0 Final 24 Jul 2026 Equity shares
    25 Jul 2025 11.0 Final 25 Jul 2025 Equity shares
    26 Jul 2024 3.0 Final 26 Jul 2024 Equity shares
    28 Jul 2023 6.0 Final 28 Jul 2023 Equity shares
    28 Jul 2022 2.5 Final 29 Jul 2022 Equity shares
    28 Jul 2021 3.5 Final 30 Jul 2021 Equity shares
    23 Mar 2020 3.5 Interim 24 Mar 2020 Equity shares
    25 Jul 2019 3.5 Final 29 Jul 2019 Equity shares
    31 Jul 2018 3.5 Final 02 Aug 2018 Equity shares
    16 Mar 2017 3.2 Interim 17 Mar 2017 Equity shares
    17 Mar 2016 3.2 Interim 18 Mar 2016 Equity shares
    30 Jul 2015 12.0 Final 03 Aug 2015 Equity shares
    17 Jul 2014 9.0 Final 21 Jul 2014 Equity shares
    11 Jun 2013 7.5 Interim 12 Jun 2013 Equity shares
    26 Jul 2012 7.5 Final 30 Jul 2012 Equity shares
    07 Jul 2011 6.25 Final 11 Jul 2011 Equity shares
    15 Jul 2010 5.0 Final 19 Jul 2010 Equity shares
    16 Jul 2009 4.5 Final 20 Jul 2009 Equity shares
    10 Jul 2008 4.5 Final 14 Jul 2008 Equity shares
    12 Jul 2007 4.0 Final 16 Jul 2007 Equity shares
    14 Jul 2005 0.0 Final 18 Jul 2005 Equity shares
    Ex-Date Ex-Bonus Ratio
    06 Apr 2010 05 Apr 2010 1:2
    31 Aug 2006 30 Aug 2006 1:1
    Ex-Date Old FV NEW FV Record Date
    06 Oct 2015 5.0 1.0 07 Oct 2015
    Dividend date Dividend amount Dividend type Record date Instrument type
    24 Jul 2026 1.0 Final 24 Jul 2026 Equity shares
    25 Jul 2025 11.0 Final 25 Jul 2025 Equity shares
    26 Jul 2024 3.0 Final 26 Jul 2024 Equity shares
    28 Jul 2023 6.0 Final 28 Jul 2023 Equity shares
    28 Jul 2022 2.5 Final 29 Jul 2022 Equity shares
    28 Jul 2021 3.5 Final 30 Jul 2021 Equity shares
    23 Mar 2020 3.5 Interim 24 Mar 2020 Equity shares
    25 Jul 2019 3.5 Final 29 Jul 2019 Equity shares
    31 Jul 2018 3.5 Final 02 Aug 2018 Equity shares
    16 Mar 2017 3.2 Interim 17 Mar 2017 Equity shares
    17 Mar 2016 3.2 Interim 18 Mar 2016 Equity shares
    30 Jul 2015 12.0 Final 03 Aug 2015 Equity shares
    17 Jul 2014 9.0 Final 21 Jul 2014 Equity shares
    11 Jun 2013 7.5 Interim 12 Jun 2013 Equity shares
    26 Jul 2012 7.5 Final 30 Jul 2012 Equity shares
    07 Jul 2011 6.25 Final 11 Jul 2011 Equity shares
    15 Jul 2010 5.0 Final 19 Jul 2010 Equity shares
    16 Jul 2009 4.5 Final 20 Jul 2009 Equity shares
    10 Jul 2008 4.5 Final 14 Jul 2008 Equity shares
    12 Jul 2007 4.0 Final 16 Jul 2007 Equity shares
    14 Jul 2005 0.0 Final 18 Jul 2005 Equity shares
    Ex-Date Ex-Bonus Ratio
    06 Apr 2010 05 Apr 2010 1:2
    31 Aug 2006 30 Aug 2006 1:1
    Ex-Date Old FV NEW FV Record Date
    06 Oct 2015 5.0 1.0 07 Oct 2015

    Top Gainers

    Top Losers

    stock
    Trade stocks with ease

    Sign-in to trade with your demat account, or set up a new demat account for free

    Board Of Directors

    Similar stocks

    Frequently Asked Questions

    What is the Current Share Price of Zydus Lifesciences Ltd?

    Answer Field

    Zydus Lifesciences Ltd share price is for NSE ₹ 1,111.80 & for BSE ₹ 1,108.90 as on Jul 24 2026 03:29 PM.

    What is the Market Cap of Zydus Lifesciences Ltd Share?

    Answer Field

    The market cap of Zydus Lifesciences Ltd for NSE ₹ 0.01 & for BSE ₹ 0.01 as on Jul 24 2026 03:29 PM.

    What is the 52 Week High and Low of Zydus Lifesciences Ltd?

    Answer Field

    The 52 Week High and Low of Zydus Lifesciences Ltd for NSE is ₹ 1,181.50 and ₹ 835.50 and for BSE is ₹ 1,181.00 and ₹ 835.85.

    What is 1 year return for Zydus Lifesciences Ltd?

    Answer Field

    The 1 year returns on the stock has been 14.15%.

    What is the P/E Ratio of Zydus Lifesciences Ltd Share?

    Answer Field

    As on Jul 24 2026 03:29 PM the price-to-earnings (PE) ratio for Zydus Lifesciences Ltd share is 31.07.

    What is the PB ratio of Zydus Lifesciences Ltd Share?

    Answer Field

    As on Jul 24 2026 03:29 PM, the price-to-book (PB) ratio for Zydus Lifesciences Ltd share is 237.30.

    How to Buy Zydus Lifesciences Ltd Share?

    Answer Field

    You can trade in Zydus Lifesciences Ltd shares with Bajaj Broking by opening a demat account.

    How to Buy Zydus Lifesciences Ltd Share on Bajaj Broking App?

    Answer Field

    To buy Zydus Lifesciences Ltd shares on the Bajaj Broking app, follow these steps:

    • Login to the Bajaj Broking App

    • Click on the Search Icon

    • Search “Zydus Lifesciences Ltd”

    • Click on the BUY icon

    • Place a buy order specifying the desired quantity of shares.

    • Click BUY again to complete the purchase

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59
    banner-icon

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |